TrialClinical journal of the American Society of Nephrology : CJASN2023

Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial.

Matias Trillini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.